Legacy Edge Advisors
ABBV icon

Legacy Edge Advisors’s AbbVie ABBV Stock Holding History

Legacy Edge Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.38M Sell
5,276
-110
-2% -$28.2K 0.12% 90
2026
Q2 		$1.36M Sell
5,386
-6
-0.1% -$1.29K 0.12% 89
2026
Q1 		$1.17M Sell
5,392
-146
-3% -$32.4K 0.12% 89
2025
Q4 		$1.27M Sell
5,538
-76
-1% -$17.3K 0.14% 85
2025
Q3 		$1.3M Sell
5,614
-101
-2% -$20.6K 0.15% 81
2025
Q2 		$1.06M Buy
5,715
+118
+2% +$21.9K 0.14% 81
2025
Q1 		$1.17M Sell
5,597
-3
-0.1% -$583 0.18% 63
2024
Q4 		$987K Sell
5,600
-105
-2% -$19.3K 0.16% 72
2024
Q3 		$1.13M Buy
5,705
+552
+11% +$103K 0.18% 67
2024
Q2 		$884K Buy
5,153
+366
+8% +$60.6K 0.16% 76
2024
Q1 		$872K Sell
4,787
-54
-1% -$9.31K 0.18% 72
2023
Q4 		$750K Buy
+4,841
New +$706K 0.17% 80

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Legacy Edge Advisors's ABBV Position: Q3 2026 in Review

Legacy Edge Advisors reduced its AbbVie (ABBV) stake by 2% in Q3 2026, selling an estimated $28.2K and leaving 5,276 shares worth $1.38M. The position accounts for 0.12% of the portfolio, ranked #90.

Legacy Edge Advisors first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Legacy Edge Advisors held 5,276 shares of AbbVie worth $1.38M as of Q3 2026.
  • Legacy Edge Advisors sold 110 AbbVie shares in Q3 2026, an estimated $28.2K.
  • AbbVie made up 0.12% of Legacy Edge Advisors's portfolio in Q3 2026, its #90 holding.
  • Legacy Edge Advisors first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Legacy Edge Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.